Visikol provides end-to-end drug discovery services that include 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology, and custom drug discovery projects. The company's expertise lies in transforming tissues into images and quantitative data sets that help clients make more informed decisions during the drug discovery process. Visikol also manufactures and sells tissue clearing reagents and 3D immuno-labeling kits that allow researchers to easily and rapidly image whole tissues and 3D cell culture models. Today, Visikol has all twenty of the top twenty pharmaceutical companies as clients and has been instrumental in dozens of drug discovery programs.